BCM
REGN icon

Bridgeway Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bridgeway Capital Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-2,600
Closed -$1.87M – 1411
2023
Q2 		$1.87M Hold
2,600
– – 0.04% 571
2023
Q1 		$2.14M Sell
2,600
-2,700
-51% -$2.04M 0.06% 504
2022
Q4 		$3.82M Sell
5,300
-5,000
-49% -$3.69M 0.1% 343
2022
Q3 		$7.09M Sell
10,300
-5,800
-36% -$3.65M 0.19% 163
2022
Q2 		$9.52M Buy
16,100
+2,600
+19% +$1.69M 0.22% 138
2022
Q1 		$9.43M Buy
+13,500
New +$8.54M 0.18% 184
2021
Q1 		– Sell
-3,840
Closed -$1.85M – 1397
2020
Q4 		$1.85M Sell
3,840
-40
-1% -$21.6K 0.04% 550
2020
Q3 		$2.17M Sell
3,880
-37,020
-91% -$22.4M 0.05% 394
2020
Q2 		$25.5M Buy
+40,900
New +$23.2M 0.52% 72
2016
Q1 		– Sell
-11,200
Closed -$6.08M – 1475
2015
Q4 		$6.08M Sell
11,200
-5,400
-33% -$2.93M 0.11% 180
2015
Q3 		$7.72M Hold
16,600
– – 0.16% 157
2015
Q2 		$8.47M Hold
16,600
– – 0.17% 146
2015
Q1 		$7.5M Hold
16,600
– – 0.15% 148
2014
Q4 		$6.81M Hold
16,600
– – 0.16% 147
2014
Q3 		$5.99M Hold
16,600
– – 0.15% 162
2014
Q2 		$4.69M Sell
16,600
-3,000
-15% -$889K 0.12% 206
2014
Q1 		$5.88M Hold
19,600
– – 0.17% 126
2013
Q4 		$5.39M Hold
19,600
– – 0.16% 125
2013
Q3 		$6.13M Hold
19,600
– – 0.21% 81
2013
Q2 		$4.41M Buy
+19,600
New +$4.56M 0.18% 101

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bridgeway Capital Management's REGN Position: Q3 2023 in Review

Bridgeway Capital Management sold out of Regeneron Pharmaceuticals (REGN) in Q3 2023, closing a stake of 2,600 shares — an estimated $1.87M sold.

Bridgeway Capital Management first reported a position in REGN in Q2 2013 and held it in 20 quarters. The position peaked at $25.5M in Q2 2020. 1,177 funds tracked by Wall St. Rank hold REGN as of Q3 2023.

  • Bridgeway Capital Management reported no remaining Regeneron Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Bridgeway Capital Management sold 2,600 Regeneron Pharmaceuticals shares in Q3 2023, an estimated $1.87M.
  • Bridgeway Capital Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 20 quarters.
  • Bridgeway Capital Management's Regeneron Pharmaceuticals position peaked at $25.5M in Q2 2020.
  • 1,177 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2023.

Based on Bridgeway Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.